This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

With Elan Deal, Perrigo Joins Long List of U.S. Corporate Tax Avoiders

Stocks in this article: PRGO ELN AMGN LLY AAPL

ALLEGAN, Mich. (But not for long) ( TheStreet) -- The roots of Perrigo (PRGO) go back 126 years. Luther Perrigo, the proprietor of a general store and apple-drying business in western Michigan, had an idea to distribute medicines and other household goods to country stores. From these humble roots, Perrigo grew into a multi-billion dollar business selling over-the-counter and generic medicines, baby formula and nutritional supplements.

Perrigo was an American business success story. That ended Monday, when the company decided to buy Irish drug maker Elan (ELN) for $8.6 billion in order to evade... um, sorry, I mean reduce... its obligation to pay U.S. taxes.

The "new" Perrigo will no longer be headquartered in Allegan, Michigan, home of the "Old Iron Bridge." The company is moving to Dublin, Ireland where Elan is headquartered and companies pay only 12.5 percent corporate income tax.

Of course, Perrigo is not physically moving to Ireland. CEO Joseph Papa and his executives aren't selling their big houses in Michigan -- watched over by cops and firemen paid for with public funding. Their kids will continue to attend school here -- some may even go to U.S. taxpayer-funded public schools! The company's trucks will drive on roads built and maintained by U.S taxpayers.

The only part of Perrigo actually moving to Ireland is its bank account. Last year, Perrigo's effective tax rate was 23 percent. That's not low enough, apparently, so Papa bought Elan and is moving the corporate books to Dublin.

Perrigo is not alone in abandoning the U.S. for an overseas tax haven. Lots of companies are doing it. Apple (AAPL) is probably the most famous U.S. income tax avoider, but in healthcare, Pfizer (PFE), Amgen (AMGN) and Eli Lilly (LLY) have all moved huge chunks of their business to tax-friendly locales.

Perrigo wins, America loses.

--Written by Adam Feuerstein in Boston.

>To contact the writer of this article, click here: Adam Feuerstein.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs